HeartFlow Raises 2026 Revenue Outlook to $262 Million to $264 Million

HeartFlow raised its 2026 revenue outlook and lifted its Plaque forecast, while projecting about 1,300 activated accounts by year-end as third-quarter sales grew 57.4% from a year earlier.

The company now expects full-year revenue of $262 million to $264 million. It raised its Plaque revenue outlook to $36 million to $37 million and expects about 1,300 Plaque-activated accounts by year-end.

HeartFlow expects Plaque pricing to be roughly flat sequentially in the fourth quarter. For the first quarter, it anticipates pricing upside of slightly more than 10% versus current consensus.

Third-quarter revenue was $72.9 million. U.S. revenue increased 60%, marking its fastest growth in 11 quarters. HeartFlow’s non-GAAP gross margin was 83.8%, and its non-GAAP operating loss narrowed to $5 million.

The company raised its 2026 gross-margin outlook to about 82.5%. It expects more operating leverage in 2027 and reiterated its target of cash flow profitability by mid-2028.

HeartFlow pointed to accelerating Plaque adoption, continued FFRCT utilization, new account additions and growth in the CCTA market as factors supporting its outlook.